Trials / Sponsors / TenNor Therapeutics Inc.
TenNor Therapeutics Inc.
Industry · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Phase 1/2 Study to Evaluate the Safety, PK and Efficacy of TNP-2092 Administered Via IA Injection in PJI Par Periprosthetic Joint Infection (PJI) | Phase 1 / Phase 2 | 2025-04-03 |
| Completed | Drug-Drug Interactions Between TNP-2198 and Midazolam, Clarithromycin Helicobacter Pylori Infection | Phase 1 | 2024-08-26 |
| Completed | Phase 1, Single-Dose and Multiple-Dose Continuous Intravenous Infusions of TNP-2092 for Injection in Healthy C Acute Bacterial Skin and Skin Structure Infection (ABSSSI), Prosthetic Joints Infection (PJI) | Phase 1 | 2022-07-07 |
| Completed | The Safety and Tolerability, Pharmacokinetics of TNP-2092 Capsules in Combination With Rabeprazole Sodium Ente Helicobacter Pylori Infection | Phase 1 | 2017-10-10 |